Cordovés QS, Suárez GM, Solis CU, Caballero GM, Muñoz BM

Language: Spanish
References: 19
Page: 166-171
PDF size: 290.43 Kb.

ABSTRACT

Introduction: the psoriasis is an inflammatory illness that has different clinical presentations, he/she can appear to any age and it is described that it can affect to both sexes although with slight prevalence in the masculine sex. Inside the multiple clinical manifestations it is to highlight the taking of the axial skeleton and peripheral being denominated psoriatic arthropatic.
Objective: to evaluate the behaviour of the patients with psoriasis and the arthropatic existence.
Methodology: I study descriptive in 63 patients with psoriasis. For the positive diagnosis they were kept in mind the approaches of the ASAS group. The demographic variable partner was described obtained through a survey that contained so much clinical elements as radiological useful to confirm the diagnosis of the illness.
Results: the patients prevailed bigger than 50 years; the masculine sex with 74.6 %, the arthritis psoriásica was more frequent in the feminine sex with 6 women. The family antecedents of psoriasis were of 57.8 % for those that suffered psoriasis and 36 % for those that also have arthritis. The time of illness of cutaneous psoriasis was bigger than the patients with arthritis. In connection with the affectation unquail, in the patients with cutaneous psoriasis showed in 15.1% and in the patients with arthritis in 63.6 %. The sick persons with arthritis began the psoriasis before in 81.8 %. The clinical form of habitual presentation of the psoriasis was of 54 % in badge and of the patients with arthritis 81.8 % presented polyarthritis.
Conclusions: the presence of ungüeal affectation is an element to keep in mind in the possible appearance of psoriatic arthritis.

REFERENCES

1. Gladman D. Psoriatic arthritis. Rheum Dis Clin North Am. 2008;24:829-44.

2. Christophers E. Psoriasis - Epidemiology and clinical spectrum. Clin Exp Dermatology. 2011;26:314-20.

3. Suárez-Martín R, Remedios-Batista S, Serrano-Espinosa I. Mecanismos inmunológicos y blanco de las lesiones inflamatorias. Revista Cubana de Reumatología [Internet]. 2013 [citado 2015 Ene 11];14(19):[aprox. 6 p.]. Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/20

4. Puig L, Carrascosa J, Daudén E, Sánchez-Carazo J, Ferrándiz C, Sánchez-Regaña M, et al. Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis moderada a grave con agentes biológicos. 2009;100(5):386-413.

5. Kirby B, Fortune D, Bhushan M, Chalmers RJG, Griffiths CEM. The Salford Psoriasis Index: An holistic measure of psoriasis severiy. Br J Dermatol. 2000;142(4):728-32.

6. Faust H, Gonin R, Chuang T, Lewis CW, Melfi CA, Farmer ER. Reliabity testing of the Dermatology Index of Disease Severity (DIDS). Arch Dermatol. 1997;133:1443-8.

7. Van de Kerkhof PCM. The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity persisting areas of confusion. Br J Dermatol. 2007;137:661-2.

8. Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol. 2011;124:565-70

9. Fernández Sueiro J, Roura X, Crespillo J, Torre J, García R, Queiro R, et al. Documento SER de consenso sobre el uso de terapias biológicas en la artritis psoriásica. Reumatología Clínica. 2011;7(3):179-88.

10. Solis-Cartas U, Morejón-Gómez J, de-Armas-Hernández A. Espondilitis anquilosante y enfermedad de Von Recklinhausen. Una asociación infrecuente. Rev Cubana Reumatol [Internet]. 2014 [citado 2014 Jul 3];16(2):[aprox. 0 p.]. Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/327

11. Biljan D, Laufer D, Filaković P, Situm M, Brataljenović T. Psoriasis, mental disorders and stress. Coll Antropol. 2009;33:889-92.

12. Márquez J, Pinto L, Candia D, Restrepo M, Uribe El, Rincón O, et al. Espondilo artritis en el Hospital Pablo Tobón Uribe. Descripción de una cohorte. Rev. Colomb. Reumatol. [Internet].2010 [citado 2015 Ene 31];17(2):80-5. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-81232010000200002&lng=en

13. Uguz F, Akman C, Kucuksarac S, Tufekci O. Anti-tumor necrosis factor-a therapy is associated with less frequen mood and anxiety disorders in patients with rheumatoid artritis. Psychiatry Clin Neurosci. 2009;63:50-5.

14. Gómez-Morales J, Blanco-Cabrera Y, Llópiz-Morales M, Reyes-Pineda Y, Solis-Cartas E. Manifestaciones oftálmicas derivadas del tratamiento de las enfermedades reumáticas. Rev Cubana Reumatol [Internet]. 2014 [citado 2015 Ene 31];17(1):[aprox. 6 p.]. Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/390

15. Márquez J, Pinto L, Candia D, Restrepo M, Uribe El, Rincón O, et al. Espondiloartritis en el Hospital Pablo Tobón Uribe. Descripción de una cohorte. Rev.Colomb.Reumatol. [Internet].2010 [citado 2015 Ene 31];17(2):80-85. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-81232010000200002&lng=en

16. Faust H, Gonin R, Chuang T, Lewis CW, Melfi, CA, Farmer ER. Reliabity testing of the Dermatology Index of Disease Severity (DIDS). Arch Dermatol. 1997;133:1443-8.

17. Freire M, Rodríguez J, Möller I, Valcárcel A, Tornero C, Díaz G, Armendáriz Y. Prevalencia de síntomas de ansiedad y de depresión en pacientes con artritis psoriásica en consultas de reumatología. Reumatol Clin. 2011;7(1):20-6.

18. Long C, Finlay Y, Averill W. The rule of hand: 4 hand areas 2 FTU = 1g. Arch Dermatol. 2012;128:1129-30.

19. Mora C, González A, Quintana L. Guía de tratamiento de la artritis reumatoide temprana en un Hospital Universitario de Colombia. Rev. Colomb Reumatol [Internet]. 2008 [citado 2015 Ene 31];15(2):79-91. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-81232008000200003&lng=en